Paul Campbell
Comptroller/Controller/Auditor bij VIATRIS INC.
Vermogen: 2 M $ op 30-04-2024
Actieve functies van Paul Campbell
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
VIATRIS INC. | Comptroller/Controller/Auditor | 16-11-2020 | - |
Loopbaan van Paul Campbell
Eerdere bekende functies van Paul Campbell
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Comptroller/Controller/Auditor | - | - |
Financieel Directeur/CFO | - | - |
Statistieken
Internationaal
Verenigd Koninkrijk | 2 |
Verenigde Staten | 2 |
Operationeel
Comptroller/Controller/Auditor | 2 |
Director of Finance/CFO | 1 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
VIATRIS INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Paul Campbell
- Ervaring